Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ob/Gyn Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ob/Gyn Other
    Breastfeeding May Protect Women From Metabolic Syndrome - (DGNews)
    FDA Approves Low-Dose Local Oestrogen Therapy for the Treatment of Atrophic Vaginitis Due to Menopause - (DGNews)
    MRI Pinpoints Placenta Accreta With High Specificity: Presented at RSNA - (DGDispatch)
    Blood Test Can Reduce Repeat Breast MRI in Women With Irregular Menstrual Cycles - (DGNews)
    Flibanserin Provides Multiple Benefits in Women With Low Sexual Desire: Presented at ESSM - (DGDispatch)

    News archive

     Recent webcasts/CME - Ob/Gyn Other
    • Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
    • Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
    • Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Hypoactive Sexual Desire Disorder in Women: Implications for Family Practice

      Webcasts/CME archive

       Recent cases - Ob/Gyn Other
        Effects of Growth Hormone Reduction in a Patient with Polycystic Ovary Syndrome Complicated with Acromegaly
        Endometriosis Presenting as an Acute Groin Swelling: A Case Report
        Giant Ovarian Serous Cystadenoma in a Postmenopausal Woman: A Case Report
        Failure of Ultrasound to Diagnose a Giant Ovarian Cyst: A Case Report
        Female Sexual Dysfunction

        Cases archive
          




        my personal edition > ob/gyn other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Balloon Tamponade Works When Oxytocin and Other Uterotonics Fail to Stop Postpartum Bleeding: Presented at ACOG

        By Maggie Schwarz

        WASHINGTON, D.C. -- May 11, 2006 -- Positive results with balloon tamponade to stop postpartum hemorrhage were reported here at the 54th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG).

        Victor G. Dabelea, MD, resident in obstetrics and gynecology, Exempla St. Joseph Hospital, Denver, Colorado, and colleagues conducted a 2-year retrospective review of 24 cases who had received oxytocin; 20 of these patients had received other uterotonics.

        In balloon tamponade of the uterus, the balloon exerts pressure on bleeding areas and stops bleeding. "This procedure is easy and efficient and would be a huge advantage in settings where you could not proceed immediately to hysterectomy. Such settings would be those where no blood products or operating room are available," Dr. Dabelea explained.

        In 3 of the 24 cases, technical difficulties led to placement failure. When properly placed, catheters controlled postpartum hemorrhage in 90.4% of 21 cases. In 2 of these cases, hysterectomy was required despite successful placement of the catheter (1 due to placenta accreta and 1 to amniotic fluid embolism).

        For hemorrhage due to uterine atony, the success rate was 100% of 12 cases. For bleeding due to retained products of conception, the success rate was 80% of 5 (failure with placenta accreta). Vaginal bleeding was stopped with the catheter in 2 of 3 cases of amniotic fluid embolus, and in 1 case after dilatation and curettage for postpartum septic shock.

        Postpartum hemorrhage complicates 3% to 5% of deliveries and may require hysterectomy or uterine artery embolization when unresponsive to oxytocin or other uterotonics, Dr. Dabelea said.

        He concluded that balloon tamponade is an effective adjunct in the treatment of severe postpartum hemorrhage, especially when the hemorrhage is due to uterine atony.


        [Presentation title: Intrauterine Balloon Tamponade in the Management of Postpartum Hemorrhage. Abstract p. 38S]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send